These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 11478919)

  • 1. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
    Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
    Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
    Sydserff SG; Borelli AR; Green AR; Cross AJ
    Br J Pharmacol; 2002 Jan; 135(1):103-12. PubMed ID: 11786485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y; Li Q; Shuaib A
    Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The free radical spin-trap alpha-PBN attenuates periinfarct depolarizations following permanent middle cerebral artery occlusion in rats without reducing infarct volume.
    Christensen T; Bruhn T; Diemer NH
    Brain Res; 2003 Nov; 990(1-2):66-76. PubMed ID: 14568331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro blood-brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions.
    Dehouck MP; Cecchelli R; Richard Green A; Renftel M; Lundquist S
    Brain Res; 2002 Nov; 955(1-2):229-35. PubMed ID: 12419541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia.
    Green AR; Lanbeck-Vallén K; Ashwood T; Lundquist S; Lindström Böö E; Jonasson H; Campbell M
    Brain Res; 2006 Feb; 1072(1):224-6. PubMed ID: 16448628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NXY-059, a nitrone with free radical trapping properties inhibits release of cytochrome c after focal cerebral ischemia.
    Han M; He QP; Yong G; Siesjö BK; Li PA
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1249-52. PubMed ID: 14983994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia.
    Cao X; Phillis JW
    Brain Res; 1994 May; 644(2):267-72. PubMed ID: 8050038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NXY-059, a free radical--trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species.
    Marshall JW; Duffin KJ; Green AR; Ridley RM
    Stroke; 2001 Jan; 32(1):190-8. PubMed ID: 11136936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat.
    Kuroda S; Tsuchidate R; Smith ML; Maples KR; Siesjö BK
    J Cereb Blood Flow Metab; 1999 Jul; 19(7):778-87. PubMed ID: 10413033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-ischemic administration of DY-9760e, a novel calmodulin antagonist, reduced infarct volume in the permanent focal ischemia model of spontaneously hypertensive rat.
    Takagi K; Sato T; Shirasaki Y; Narita K; Tamura A; Sano K
    Neurol Res; 2001 Sep; 23(6):662-8. PubMed ID: 11547940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infarct tolerance induced by intra-cerebral infusion of recombinant brain-derived neurotrophic factor.
    Yanamoto H; Nagata I; Sakata M; Zhang Z; Tohnai N; Sakai H; Kikuchi H
    Brain Res; 2000 Mar; 859(2):240-8. PubMed ID: 10719070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia.
    Lavie G; Teichner A; Shohami E; Ovadia H; Leker RR
    Brain Res; 2001 May; 901(1-2):195-201. PubMed ID: 11368967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDL 101,002, a free radical spin trap, is efficacious in permanent and transient focal ischemia models.
    Johnson MP; McCarty DR; Velayo NL; Markgraf CG; Chmielewski PA; Ficorilli JV; Cheng HC; Thomas CE
    Life Sci; 1998; 63(4):241-53. PubMed ID: 9698033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the nitrone radical scavengers PBN and S-PBN on in vivo trapping of reactive oxygen species after traumatic brain injury in rats.
    Marklund N; Lewander T; Clausen F; Hillered L
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1259-67. PubMed ID: 11702041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A.
    Yoshimoto T; Kristián T; Hu B; Ouyang YB; Siesjö BK
    Brain Res; 2002 Apr; 932(1-2):99-109. PubMed ID: 11911866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats.
    Xue D; Slivka A; Buchan AM
    Stroke; 1992 Jun; 23(6):894-9. PubMed ID: 1595111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
    Slivka AP; Murphy EJ
    Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of the novel brain-penetrating antioxidant U-101033E and the spin-trapping agent alpha-phenyl-N-tert-butyl nitrone (PBN).
    Schmid-Elsaesser R; Hungerhuber E; Zausinger S; Baethmann A; Reulen HJ
    Exp Brain Res; 2000 Jan; 130(1):60-6. PubMed ID: 10638441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke.
    Maples KR; Green AR; Floyd RA
    CNS Drugs; 2004; 18(15):1071-84. PubMed ID: 15581379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.